Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world’s leading cause of disability, in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Antonietta Vilella, Barbara Ruozi, Daniela Belletti, Francesca Pederzoli, Marianna Galliani, Valentina Semeghini, Flavio Forni, Michele Zoli, Maria Angela Vandelli, Giovanni Tosi
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2015-06-01
Col·lecció:	Pharmaceutics
Matèries:	nanomedicine blood brain barrier neuron endocytosis cellular uptake
Accés en línia:	http://www.mdpi.com/1999-4923/7/2/74
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!